GOLD COSMETICS BLEACH CREAM FORTE- hydroquinone cream cream 
Peer Pharm Ltd

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Bleach Cream Forte

Hydroquinone 8%

Face cream for gradual fading of dark spots

Face cream for gradual fading of dark spots

Apply a very thin layer once a day, only at night, all over the face

Apply a very thin layer once a day, only at night, all over the face​

Sun exposure should be limit by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin
when using and after using this product in order to prevent darkening from reoccurring.

Proper use of skin bleaching creams is extremely important, and directions should be followed carefully at all times.

Large skin areas, such as the entire face, should not be bleached at once due to the possibility of skin discoloration.

Product should be used on the darkened area of skin only.

For external use only.

Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if condition worsens or does not improve after regular use as directed.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children

Bleach Forte

GOLD COSMETICS BLEACH CREAM FORTE 
hydroquinone cream cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69435-1901
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE8 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
JOJOBA OIL (UNII: 724GKU717M)  
DECYL OLEATE (UNII: ZGR06DO97T)  
SODIUM DITHIONATE (UNII: RPF7Z41GAW)  
XANTHAN GUM (UNII: TTV12P4NEE)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
WATER (UNII: 059QF0KO0R)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
CETEARETH-30 (UNII: 1R9DCZ5FOX)  
STEARETH-21 (UNII: 53J3F32P58)  
STEARETH-2 (UNII: V56DFE46J5)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
ALLANTOIN (UNII: 344S277G0Z)  
ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69435-1901-130 mL in 1 TUBE; Type 0: Not a Combination Product09/05/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart358A09/05/2019
Labeler - Peer Pharm Ltd (514678390)
Registrant - Peer Pharm Ltd (514678390)
Establishment
NameAddressID/FEIBusiness Operations
Peer Pharm Ltd514678390manufacture(69435-1901) , label(69435-1901)

Revised: 9/2019
Document Id: 91cf6335-77f5-3f01-e053-2995a90a95d2
Set id: 91cf6335-77f6-3f01-e053-2995a90a95d2
Version: 1
Effective Time: 20190905
 
Peer Pharm Ltd